课题基金 / 基金详情

Novel vaccines and serotyping scheme for Haemophilus parasuis

Novel vaccines and serotyping scheme for Haemophilus parasuis
副猪嗜血杆菌新型疫苗和血清分型方案
批准号:
ARC : LP0218929
负责人:
Dr Michael Jennings
金额:
$17.43万
依托单位国家:
澳大利亚
项目类别:
Linkage Projects
财政年份:
2002
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2002-01-01 至 2004-12-31

项目摘要

项目成果

Dr Michael Jennings的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Novel vaccines and serotyping scheme for Haemophilus parasuis. Glasser's disease, caused by the bacterium Haemophilus parasuis, is a significant problem in Australian and overseas pig industries. Current approaches to the management of Glassers disease utilise antibacterials and also vaccines. However, antibacterials are of limited effectiveness in juvenile pigs (weaners) that are difficult to medicate other than by injection, and current vaccines are only protective against the serotypes included in the vaccine. We propose to examine the immune response to natural infection and identify potential vaccine candidates which will then be tested in vaccine trials. The APAI will focus on developing a DNA-based typing scheme for H. parasuis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular mechanisms of pilin glycosylation in Neisseria: a model system for protein glycosylation in bacteria.
  • 批准号:
    ARC : DP0210205
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $26.1万
  • 财政年份:
    2002
  • 负责人:
    Dr Michael Jennings
  • 依托单位:
国内基金
海外基金
基于短寿蛋白肿瘤疫苗诱导的抗瘤作用及其机制的研究
  • 批准号:
    30771999
  • 项目类别:
    面上项目
  • 资助金额:
    33.0万元
  • 批准年份:
    2007
  • 负责人:
    王立新
  • 依托单位: